| Literature DB >> 23192177 |
Abstract
Two studies in this issue identify the landscape of somatic mutations in Burkitt lymphoma and highlight the pathogenic and clinical relevance of inactivating mutations of ID3, an inhibitor of the TCF3 transcription factor.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23192177 DOI: 10.1038/ng.2476
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330